We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
WDR18
SECTIONS
  • TISSUE
  • BRAIN
  • SINGLE CELL TYPE
  • TISSUE CELL TYPE
  • PATHOLOGY
  • DISEASE
  • IMMUNE CELL
  • BLOOD PROTEIN
  • SUBCELLULAR
  • CELL LINE
  • STRUCTURE
  • INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
  • SARS-COV-2
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Patient ID
Tissue
Category
Cluster
Reliability
Brain region
Category
Brain region
Category
Brain region
Category
Cluster
Reliability
Cell type
Category
Cluster
Tissue
Cell type
Enrichment
Cancer
Prognosis
Cancer
Category
Cell type
Category
Cell lineage
Category
Cluster
Annotation
Disease
Location
Searches
Location
Cell line
Type
Phase
Reliability
Cancer type
Category
Cluster
Interacting gene
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Protein structure
In atlas
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • TISSUE CELL

  • PATHOLOGY

  • DISEASE

  • IMMUNE

  • BLOOD

  • SUBCELL

  • CELL LINE

  • STRUCTURE

  • INTERACTION

  • WDR18
TISSUE PRIMARY DATA PONS Show tissue menu
ADIPOSE TISSUE ADRENAL GLAND AMYGDALA APPENDIX BASAL GANGLIA BONE MARROW BREAST BRONCHUS CEREBELLUM CEREBRAL CORTEX CERVIX CHOROID PLEXUS COLON DUODENUM
ENDOMETRIUM EPIDIDYMIS ESOPHAGUS FALLOPIAN TUBE GALLBLADDER HEART MUSCLE HIPPOCAMPAL FORMATION HYPOTHALAMUS KIDNEY LIVER LUNG LYMPH NODE MIDBRAIN NASOPHARYNX
ORAL MUCOSA OVARY PANCREAS PARATHYROID GLAND PITUITARY GLAND PLACENTA PROSTATE RECTUM RETINA SALIVARY GLAND SEMINAL VESICLE SKELETAL MUSCLE SKIN SMALL INTESTINE
SMOOTH MUSCLE SOFT TISSUE SPINAL CORD SPLEEN STOMACH TESTIS THYMUS THYROID GLAND TONGUE TONSIL URINARY BLADDER VAGINA
ANTIBODIES
AND
VALIDATION
Dictionary
Tissue proteome
Pons
PONS - Expression summary
Protein expressioni

On the top, protein expression in current human tissue, based on all annotated cell types, is reported with the units not detected (n), low (l), medium (m) and high (h). Underneath, protein expression in each annotated cell type are reported using the same units.

Protein expression data is based on knowledge-based annotation. For genes where more than one antibody has been used, a collective score is set.

If knowledge-based annotation could not be performed for a gene, no data is displayed here. View antibody staining data further down this page.

No data
RNA expressioni

A summary of mRNA expression data available for current tissue based on several datasets. The mRNA expression levels in human tissues are based on RNA-seq data generated by the Human Protein Atlas (HPA), Genotype-Tissue Expression (GTEx) portal and CAGE data generated by the FANTOM5 consortium. Consensus normalized expression levels for human tissues was created by combining the data from HPA and GTEx datasets.

The mRNA expression levels in pig are based on RNA-seq data generated by the Human Protein Atlas (HPA), and for mouse, HPA data and in situ hybridization generated by the Allen brain atlas are reported.

Scroll down to view mRNA expression data in more detail.
HPA Brain:21.6 nTPM
FANTOM5:11.4 Scaled Tags Per Million
Pig:15.1 nTPM
Allen mouse:1.1 Expression energy

PONS - HPA Brain RNA-seq
Max nTPM 21.6
Sample id Sample description nTPM
Anterior cochlear nucleus, ventral
nTPM: 17.9
2301 Female, age 85, both hemispheres 18.5
1984 Male, age 76, both hemispheres 18.2
2090 Male, age 80, both hemispheres 17.5
2188 Female, age 91, both hemispheres 17.5
Dorsal cochlear nucleus
nTPM: 17.1
2370 Male, age 61, both hemispheres 19.3
2058 Male, age 76, both hemispheres 17.9
2187 Female, age 91, both hemispheres 16.9
2802 Male, age 74, right hemisphere 15.8
2378 Male, age 80, both hemispheres 15.4
Dorsal tegmental nucleus
nTPM: 18.2
2358 Male, age 61, both hemispheres 20.0
1936 Male, age 76, left hemisphere 18.0
2083 Male, age 80, both hemispheres 18.0
2326 Male, age 74, both hemispheres 16.8
Dorsolateral tegmental area
nTPM: 17.7
2337 Male, age 61, both hemispheres 20.0
2751 Female, age 85, both hemispheres 17.4
2360 Male, age 74, both hemispheres 17.3
2654 Male, age 80, both hemispheres 17.3
2141 Male, age 76, both hemispheres 16.4
Kolliker-Fuse nucleus
nTPM: 18.3
2163 Male, age 80, both hemispheres 20.0
2315 Male, age 76, right hemisphere 17.6
2793 Female, age 91, left hemisphere 17.4
Lateral lemniscal nuclei
nTPM: 19.3
2169 Male, age 76, both hemispheres 20.6
2746 Female, age 85, left hemisphere 20.0
2036 Male, age 80, both hemispheres 19.1
2320 Female, age 91, left hemisphere 18.6
2453 Male, age 74, right hemisphere 18.4
Lateral parabrachial nucleus
nTPM: 17.8
2139 Female, age 85, right hemisphere 20.3
2790 Male, age 61, both hemispheres 19.2
2013 Male, age 80, both hemispheres 18.2
2792 Male, age 76, both hemispheres 13.6
Lateral vestibular nucleus
nTPM: 18.7
2184 Male, age 76, both hemispheres 20.8
2311 Male, age 80, both hemispheres 16.7
Locus coeruleus
nTPM: 17.3
1980 Male, age 76, both hemispheres 19.8
2123 Female, age 91, both hemispheres 19.0
2317 Female, age 72, unknown 18.1
2014 Male, age 55, unknown 17.4
2162 Male, age 80, both hemispheres 17.4
2720 Male, age 74, both hemispheres 16.2
2788 Male, age 74, unknown 12.8
Medial parabrachial nucleus
nTPM: 18.5
2156 Male, age 61, both hemispheres 23.0
2463 Female, age 85, right hemisphere 19.0
2170 Female, age 91, both hemispheres 17.6
2786 Male, age 76, both hemispheres 16.7
2854 Male, age 80, both hemispheres 16.3
Medial periolivary nuclei
nTPM: 20.1
2063 Male, age 76, both hemispheres 22.5
2171 Female, age 85, both hemispheres 22.3
2081 Male, age 80, both hemispheres 19.4
2791 Male, age 74, right hemisphere 18.7
2458 Female, age 91, both hemispheres 17.5
Motor facial nucleus
nTPM: 19.0
2062 Male, age 76, both hemispheres 22.0
2327 Male, age 80, both hemispheres 20.7
2365 Male, age 74, right hemisphere 20.6
2126 Male, age 61, both hemispheres 17.5
2795 Female, age 91, both hemispheres 17.1
2697 Female, age 85, both hemispheres 16.2
Motor trigeminal nucleus
nTPM: 18.8
2335 Male, age 61, both hemispheres 20.6
2560 Male, age 74, both hemispheres 19.6
2079 Male, age 80, both hemispheres 19.1
2321 Female, age 91, both hemispheres 17.6
2309 Male, age 76, both hemispheres 16.8
Nuclei of the trapezoid body
nTPM: 20.8
2735 Female, age 85, both hemispheres 23.8
1983 Male, age 76, both hemispheres 21.7
2159 Male, age 61, both hemispheres 21.1
2166 Male, age 80, both hemispheres 19.0
2368 Female, age 91, both hemispheres 18.5
Nucleus raphe magnus
nTPM: 20.6
2160 Male, age 61, both hemispheres 22.2
2172 Female, age 85, both hemispheres 22.2
2455 Male, age 74, both hemispheres 21.8
2051 Male, age 76, both hemispheres 20.4
2328 Male, age 80, both hemispheres 20.1
2459 Female, age 91, both hemispheres 16.8
Paramedian reticular nucleus
nTPM: 17.5
2050 Female, age 85, both hemispheres 19.4
2313 Male, age 61, both hemispheres 19.4
2057 Male, age 80, both hemispheres 17.7
2052 Male, age 76, both hemispheres 13.6
Pedunculopontine tegmental nucleus
nTPM: 16.1
2334 Male, age 80, both hemispheres 17.2
1921 Female, age 85, both hemispheres 16.5
2338 Male, age 61, both hemispheres 14.5
Pontine nuclei
nTPM: 21.6
2787 Female, age 85, both hemispheres 27.1
1968 Male, age 76, left hemisphere 23.6
1863 Male, age 55, unknown 22.3
2109 Female, age 72, unknown 21.3
2727 Male, age 61, right hemisphere 20.8
2115 Male, age 80, left hemisphere 20.5
2454 Male, age 74, left hemisphere 19.3
2319 Female, age 91, both hemispheres 17.5
Pontine raphe nucleus
nTPM: 19.7
2122 Female, age 85, midline 20.9
2853 Male, age 76, midline 18.5
Posteroventral cochlear nucleus
nTPM: 16.8
2070 Male, age 76, both hemispheres 17.7
2371 Male, age 61, both hemispheres 17.3
2752 Female, age 85, both hemispheres 17.0
2135 Female, age 91, both hemispheres 16.6
2341 Male, age 80, both hemispheres 15.4
Principal sensory trigeminal nucleus
nTPM: 19.5
2158 Male, age 61, both hemispheres 22.1
2324 Male, age 76, both hemispheres 19.5
2367 Female, age 91, left hemisphere 18.4
2008 Male, age 80, left hemisphere 17.9
Reticular pontine nucleus, caudal
nTPM: 19.7
2332 Male, age 80, right hemisphere 22.1
2092 Male, age 76, both hemispheres 20.1
2457 Female, age 91, both hemispheres 19.2
2559 Male, age 74, both hemispheres 17.6
Reticular pontine nucleus, oral
nTPM: 18.3
2361 Male, age 74, both hemispheres 22.6
2012 Female, age 85, both hemispheres 17.9
2366 Female, age 91, both hemispheres 17.8
2167 Male, age 76, both hemispheres 17.5
1939 Male, age 80, both hemispheres 15.5
Reticulotegmental nucleus
nTPM: 18.3
2452 Male, age 74, both hemispheres 19.4
2325 Male, age 76, both hemispheres 18.6
2333 Male, age 80, both hemispheres 18.5
2322 Female, age 91, both hemispheres 16.5
Spinal trigeminal nucleus, oral
nTPM: 18.9
2737 Female, age 85, both hemispheres 20.8
2164 Male, age 80, both hemispheres 18.3
1978 Male, age 76, both hemispheres 17.7
Subcoeruleus area
nTPM: 17.5
2089 Male, age 76, left hemisphere 19.4
2323 Female, age 91, left hemisphere 18.3
2451 Male, age 74, both hemispheres 16.7
2369 Female, age 85, left hemisphere 16.6
1958 Male, age 80, both hemispheres 16.3
Superior olive
nTPM: 19.6
2364 Male, age 74, right hemisphere 21.3
2020 Male, age 76, both hemispheres 19.8
2329 Male, age 80, right hemisphere 19.8
1875 Female, age 85, both hemispheres 19.7
2561 Female, age 91, both hemispheres 17.2
Ventral periolivary nuclei
nTPM: 19.6
2130 Female, age 85, both hemispheres 22.2
2165 Male, age 80, both hemispheres 20.7
2794 Female, age 91, left hemisphere 17.8
2023 Male, age 76, both hemispheres 17.6
Ventrolateral tegmental area, A5 NE cell group
nTPM: 18.4
2449 Male, age 74, both hemispheres 20.5
2456 Female, age 91, both hemispheres 19.7
2161 Male, age 80, both hemispheres 19.6
1959 Male, age 76, both hemispheres 19.2
2840 Female, age 85, both hemispheres 17.2
2359 Male, age 61, both hemispheres 14.1

PONS - FANTOM5 CAGEi

RNA expression in human tissues obtained through Cap Analysis of Gene Expression (CAGE) generated by the FANTOM5 project are reported as Scaled Tags Per Million.

Max Scaled Tags Per Million 11.4
FANTOM5 sample id Sample description Scaled Tags Per Million
Locus coeruleus
Scaled Tags Per Million: 11.4
FF:10165-103B3 76 years, female 13.2
FF:10182-103D2 60 years, female 9.7
Pons
Scaled Tags Per Million: 9.8
FF:10033-101E6 18-54 years, mixed 9.8

PONS - Pig RNA-seqi

RNA-seq data obtained from pig brain is reported as nTPM .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. nTPM values of the individual samples are presented next to the box plot.
Average nTPM 15.1
Pig sample Sample description nTPM
Pons
nTPM: 15.1
Samples: 4

Max nTPM: 20.4
Min nTPM: 11.0
Sample A Female 20.4
Sample B Female 11.0
Sample C Male 13.0
Sample D Male 15.9

PONS - Allen Mouse ISHi

In situ hybridization (ISH) data generated by the Allen brain atlas from mouse brain is reported as expression energy. For more details about a particular experiment, click on the corresponding Allen experiment ID.

Max Expression energy 1.1
Allen experiment id Experiment description Expression energy
Pons
Expression energy: 1.1
1552 Antisense, RP_Baylor_103362, Mouse strain C57BL/6J (56 days, male) 1.1
1551 Antisense, RP_Baylor_103362, Mouse strain C57BL/6J (56 days, male) 0.3

Contact

  • NEWS ARTICLES
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.